19-1207022-C-T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000455.5(STK11):c.109C>T(p.Gln37*) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. Q37Q) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000455.5 stop_gained
Scores
Clinical Significance
Conservation
Publications
- familial pancreatic carcinomaInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- Peutz-Jeghers syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Orphanet, Genomics England PanelApp, G2P
- familial ovarian cancerInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| STK11 | NM_000455.5 | c.109C>T | p.Gln37* | stop_gained | Exon 1 of 10 | ENST00000326873.12 | NP_000446.1 | |
| STK11 | NM_001407255.1 | c.109C>T | p.Gln37* | stop_gained | Exon 1 of 9 | NP_001394184.1 | ||
| STK11 | NR_176325.1 | n.1245C>T | non_coding_transcript_exon_variant | Exon 1 of 11 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| STK11 | ENST00000326873.12 | c.109C>T | p.Gln37* | stop_gained | Exon 1 of 10 | 1 | NM_000455.5 | ENSP00000324856.6 | ||
| STK11 | ENST00000652231.1 | c.109C>T | p.Gln37* | stop_gained | Exon 1 of 9 | ENSP00000498804.1 | ||||
| STK11 | ENST00000593219.6 | n.109C>T | non_coding_transcript_exon_variant | Exon 1 of 11 | 3 | ENSP00000466610.1 | ||||
| STK11 | ENST00000585748.3 | c.-82-11395C>T | intron_variant | Intron 3 of 11 | 3 | ENSP00000477641.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Peutz-Jeghers syndrome Pathogenic:3
For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in STK11 are known to be pathogenic. This particular variant has been reported in the literature in at least one individual with Peutz-Jeghers syndrome (PMID: 15188174). This sequence change creates a premature translational stop signal at codon 37 (p.Gln37*) of the STK11 gene. It is expected to result in an absent or disrupted protein product. -
- -
This variant is considered pathogenic. This variant creates a termination codon and is predicted to result in premature protein truncation. -
not provided Pathogenic:1
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 15188174, 16707622, 30528796, 24998845) -
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.Q37* pathogenic mutation (also known as c.109C>T), located in coding exon 1 of the STK11 gene, results from a C to T substitution at nucleotide position 109. This changes the amino acid from a glutamine to a stop codon within coding exon 1. This mutation has been reported in multiple individuals fulfilling criteria for a clinical diagnosis of Peutz-Jeghers syndrome (PJS) (Lim W et al. Gastroenterology. 2004 Jun;126(7):1788-94; Hearle N et al. Clin Cancer Res. 2006 May 15;12(10):3209-15; Jiang YL et al. Cancer Genet, 2019 01;230:47-57). In addition, in vivo functional studies demonstrate that this alteration confers tumorigenicity (Dahmani R et al. Oncogene, 2015 Apr;34:2337-46). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at